ZIOPHARM Oncology, Inc. (ZIOP) Posts Mixed Q1 Results
Tweet Send to a FriendGet Alerts ZIOP Hot Sheet
Price: $1.80 +7.78%
Revenue Growth %: -20.0%
Financial Fact:
General and administrative: 4.67M
Today's EPS Names:
BORN, EFUT, ZOOM, More
Revenue Growth %: -20.0%
Financial Fact:
General and administrative: 4.67M
Today's EPS Names:
BORN, EFUT, ZOOM, More
Trade ZIOP Now!
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q1 EPS of ($0.32), $0.09 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Hastings Entertainment (HAST) Posts Q1 Loss of 27c/Share; Comps Down 4.7%
- Wal-mart (WMT) Posts Q1 EPS of $1.14; U.S. Comps Down 1.4%; Guides Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
